Overview

Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI)

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
To compare the bacteriological eradication rates of Finafloxacin and Ciprofloxacin in female patients with uUTI.
Phase:
Phase 2
Details
Lead Sponsor:
MerLion Pharmaceuticals GmbH
Treatments:
Ciprofloxacin
Finafloxacin
Fluoroquinolones